With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
August 1, 2011
Meet some of the people featured in the August 2011 issue of The Scientist.
Unlike human brains, chimpanzee brains don’t get smaller as they age, suggesting that pronounced neurological decline is a uniquely human byproduct of our oversized brains and extreme longevity.
Eleanor Simpson, a neuroscientist at Columbia University Medical Center, discusses a recent Nature paper that probes dopamine's role in helping animals make positive associations to stimuli that herald pleasurable outcomes (such as the handing out of food).
The neural nexus of the circadian clock shows signs of functional decline as mice age, providing clues as to why sleep patterns tend to change as people grow older.
Researchers find that an ingredient in common cough medicine improves multiple sclerosis symptoms in animal models.
The Royal Society's annual science extravaganza packs some interesting stuff into 5 days of love and research.
Particulates in the air can cause impaired learning and depression in mice.